NASDAQ Composite Index

NASDAQ Composite Index handeln
26.213,72 PKT +393,58 PKT +1,52 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 969427

ISIN XC0009694271


Analysen zu NASDAQ Composite Index-Werten

Datum Rating Analyst
06.02.12 Wynn Resorts overweight Barclays Capital
06.02.12 Vertex Pharmaceuticals neutral Goldman Sachs Group Inc.
06.02.12 Royal Gold sector perform Scotia Capital Markets
06.02.12 Gilead Sciences buy Deutsche Bank Securities
03.02.12 Open Text outperform Morgan Keegan & Co., Inc.
03.02.12 Microchip Technology buy Stifel, Nicolaus & Co., Inc.
03.02.12 Gilead Sciences buy Needham & Company, LLC
03.02.12 Patterson-UTI Energy neutral UBS AG
03.02.12 Royal Gold buy UBS AG
03.02.12 BlackBerry neutral UBS AG
03.02.12 Amazon overweight Morgan Stanley
03.02.12 QUALCOMM sector outperform Scotia Capital Markets
03.02.12 Open Text outperform Raymond James Financial, Inc.
03.02.12 Open Text sector outperform Scotia Capital Markets
03.02.12 Logitech neutral Sarasin Research
03.02.12 QUALCOMM buy Goldman Sachs Group Inc.
03.02.12 QUALCOMM overweight Barclays Capital
03.02.12 Volvo (B) hold Société Générale Group S.A. (SG)
03.02.12 Amazon neutral Credit Suisse Group
03.02.12 Open Text outperform RBC Capital Markets
03.02.12 QUALCOMM buy D.A. Davidson & Co.
03.02.12 QUALCOMM outperform Pacific Crest Securities Inc.
03.02.12 QUALCOMM outperform RBC Capital Markets
03.02.12 Electronic Arts sell Deutsche Bank Securities
03.02.12 QUALCOMM buy Deutsche Bank Securities
03.02.12 Altaba overweight Piper Jaffray & Co.
02.02.12 QUALCOMM outperform Oppenheimer & Co. Inc.
02.02.12 Open Text buy Stifel, Nicolaus & Co., Inc.
02.02.12 QUALCOMM buy UBS AG
02.02.12 Apple overweight Piper Jaffray & Co.
02.02.12 Amazon buy Citigroup Corp.
02.02.12 Amazon buy Deutsche Bank Securities
02.02.12 Amazon neutral Nomura
02.02.12 Apple overweight Barclays Capital
02.02.12 Ceva overweight Barclays Capital
02.02.12 Amazon outperform RBC Capital Markets
02.02.12 Amazon outperform Macquarie Research
02.02.12 Biogen overweight Barclays Capital
02.02.12 Vertex Pharmaceuticals overweight Barclays Capital
02.02.12 Biogen outperform RBC Capital Markets